A Study To Evaluate The Dose Response And Safety Of PHA-794428 In Adults With Growth Hormone Deficiency

PHASE2TerminatedINTERVENTIONAL
Enrollment

136

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions
Growth Hormone Deficiency
Interventions
DRUG

PHA-794428

Trial Locations (35)

2100

Pfizer Investigational Site, Koebenhavn OE

2650

Pfizer Investigational Site, Edegem

2730

Pfizer Investigational Site, Herlev

3000

Pfizer Investigational Site, Leuven

9000

Pfizer Investigational Site, Ghent

10126

Pfizer Investigational Site, Torino

13385

Pfizer Investigational Site, Marseille

15706

Pfizer Investigational Site, Santiago de Compostela

18012

Pfizer Investigational Site, Granada

20122

Pfizer Investigational Site, Milan

35043

Pfizer Investigational Site, Marburg

51092

Pfizer Investigational Site, Reims

75013

Pfizer Investigational Site, Paris

80131

Pfizer Investigational Site, Napoli

80804

Pfizer Investigational Site, München

98125

Pfizer Investigational Site, Messina

500 05

Pfizer Investigational Site, Hradec Králové

128 08

Pfizer Investigational Site, Prague

DK-8000

Pfizer Investigational Site, Aarhus C

DK-5000

Pfizer Investigational Site, Odense C

01307

Pfizer Investigational Site, Dresden

00168

Pfizer Investigational Site, Roma

2333 ZA

Pfizer Investigational Site, Leiden

93-338

Pfizer Investigational Site, Lodz

50-367

Pfizer Investigational Site, Wroclaw

034 91

Pfizer Investigational Site, Ľubochňa

826 06

Pfizer Investigational Site, Bratislava

03010

Pfizer Investigational Site, Alicante

413 45

Pfizer Investigational Site, Gothenburg

581 85

Pfizer Investigational Site, Linköping

221 85

Pfizer Investigational Site, Lund

901 85

Pfizer Investigational Site, Umeå

EC1A 7BE

Pfizer Investigational Site, London

M20 4BX

Pfizer Investigational Site, Manchester

OX3 7LJ

Pfizer Investigational Site, Oxford

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00308464 - A Study To Evaluate The Dose Response And Safety Of PHA-794428 In Adults With Growth Hormone Deficiency | Biotech Hunter | Biotech Hunter